Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Brotchie

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|April 1, 1997
Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slicesY P Maneuf, J M Brotchie
European Journal of Neurology|December 5, 2002
5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapyS L Nicholson, J M Brotchie
Neuropharmacology|February 12, 2022
Special Issue on new therapeutic approaches to Parkinson diseaseS H Fox, J M Brotchie
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's diseaseS H Fox, J M Brotchie
British Journal of Pharmacology|December 22, 1999
The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted ratM P Hill, J M Brotchie
Journal of Neural Transmission (Vienna, Austria : 1996)|December 23, 2004
Levodopa-induced dyskinesia in Parkinson's diseaseJ M Brotchie, J Lee, K Venderova
Experimental Neurology|March 11, 1999
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned ratB Henry, A R Crossman, J M Brotchie
Nature Reviews. Neuroscience|August 3, 2001
Pathophysiology of levodopa-induced dyskinesia: potential for new therapiesE Bezard, J M Brotchie, C E Gross
Experimental Neurology|June 6, 1998
Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's diseaseS H Fox, B Moser, J M Brotchie
Experimental Neurology|June 26, 1998
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's diseaseB Henry, A R Crossman, J M Brotchie
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|April 1, 1997
Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slicesY P Maneuf, J M Brotchie
European Journal of Neurology|December 5, 2002
5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapyS L Nicholson, J M Brotchie
Neuropharmacology|February 12, 2022
Special Issue on new therapeutic approaches to Parkinson diseaseS H Fox, J M Brotchie
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's diseaseS H Fox, J M Brotchie
British Journal of Pharmacology|December 22, 1999
The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted ratM P Hill, J M Brotchie
Journal of Neural Transmission (Vienna, Austria : 1996)|December 23, 2004
Levodopa-induced dyskinesia in Parkinson's diseaseJ M Brotchie, J Lee, K Venderova
Experimental Neurology|March 11, 1999
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned ratB Henry, A R Crossman, J M Brotchie
Nature Reviews. Neuroscience|August 3, 2001
Pathophysiology of levodopa-induced dyskinesia: potential for new therapiesE Bezard, J M Brotchie, C E Gross
Experimental Neurology|June 6, 1998
Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's diseaseS H Fox, B Moser, J M Brotchie
Experimental Neurology|June 26, 1998
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's diseaseB Henry, A R Crossman, J M Brotchie
Pageof 6